Published in Cell on September 01, 1985
G-protein ligands inhibit in vitro reactions of vacuole inheritance. J Cell Biol (1994) 2.51
Kinetic analysis of receptor-activated phosphoinositide turnover. J Cell Biol (2003) 1.81
The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate production. Proc Natl Acad Sci U S A (1997) 1.78
Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains. Proc Natl Acad Sci U S A (1994) 1.72
Regulatory pathways governing modulation of fungal gene expression by a virulence-attenuating mycovirus. EMBO J (1992) 1.52
Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor. J Virol (1987) 1.36
Inositol phospholipid metabolism may trigger flagellar excision in Chlamydomonas reinhardtii. J Cell Biol (1992) 1.34
vph6 mutants of Saccharomyces cerevisiae require calcineurin for growth and are defective in vacuolar H(+)-ATPase assembly. Genetics (1995) 1.24
Epidermal growth factor mimics insulin effects in rat hepatocytes. Biochem J (1986) 1.14
Thrombin exerts a dual effect on stimulated adenylate cyclase in hamster fibroblasts, an inhibition via a GTP-binding protein and a potentiation via activation of protein kinase C. Biochem J (1988) 1.12
Stimulation of choline release from NG108-15 cells by 12-O-tetradecanoylphorbol 13-acetate. Biochem J (1987) 1.10
The role of the inositol phosphate cascade in visual excitation of invertebrate microvillar photoreceptors. J Gen Physiol (1991) 1.06
Altered transcriptional response to nutrient availability in hypovirus-infected chestnut blight fungus. EMBO J (1994) 1.01
Co-activation of P2Y2 receptor and TRPV channel by ATP: implications for ATP induced pain. Cell Mol Neurobiol (2005) 0.99
Studies on protein kinases involved in regulation of nucleocytoplasmic mRNA transport. Biochem J (1988) 0.96
Neomycin cannot be used as a selective inhibitor of inositol phospholipid hydrolysis in intact or semi-permeabilized human platelets. Aminoglycosides activate semi-permeabilized platelets. Biochem J (1987) 0.96
Role of phosphatidylinositide metabolism in ras-induced Xenopus oocyte maturation. Mol Cell Biol (1990) 0.94
Epigallocatechin-3-gallate increases intracellular [Ca2+] in U87 cells mainly by influx of extracellular Ca2+ and partly by release of intracellular stores. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.93
Stimulation of polyphosphoinositide hydrolysis by thrombin in membranes from human fibroblasts. Biochem J (1987) 0.91
Polyphosphoinositide breakdown and subsequent exocytosis in the Ca2+/ionophore-induced acrosome reaction of mammalian spermatozoa. Biochem J (1989) 0.90
Thrombin-stimulated events in cultured vascular smooth-muscle cells. Biochem J (1991) 0.89
Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independence from blood coagulation. EMBO J (1989) 0.89
External ATP mimics carbachol in initiating calcium mobilization from pancreatic beta-cells conditioned by previous exposure to glucose. Br J Pharmacol (1987) 0.88
Role of G-proteins in T cell activation: non-hydrolysable GTP analogues induce early ornithine decarboxylase activity in human T lymphocytes. EMBO J (1986) 0.87
Cyclophilin-dependent stimulation of transcription by cyclosporin A. Proc Natl Acad Sci U S A (1993) 0.85
Endothelial cell growth factor and ionophore A23187 stimulation of production of inositol phosphates in porcine aorta endothelial cells. Proc Natl Acad Sci U S A (1988) 0.85
Cytosolic rat brain synapsin I is a diacylglycerol kinase. Proc Natl Acad Sci U S A (1991) 0.85
Mitogenic regulation of normal and malignant breast epithelium. Yale J Biol Med (1990) 0.82
Transmodulation of the epidermal-growth-factor receptor in permeabilized 3T3 cells. Biochem J (1988) 0.81
Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins. Eur J Pharmacol (2010) 0.80
The role of diacylglycerol in the exocytosis of the sperm acrosome. Studies using diacylglycerol lipase and diacylglycerol kinase inhibitors and exogenous diacylglycerols. Biochem J (1992) 0.80
Neomycin does not interfere with the inositol phospholipid metabolism, but blocks binding of alpha-thrombin to intact human platelets. Biochem J (1991) 0.79
Hygromycin B inhibits synthesis of murine coronavirus RNA. Antimicrob Agents Chemother (1991) 0.79
Neomycin induces stimulatory and inhibitory effects on leukotriene generation, guanine triphosphatase activity, and actin polymerization within human neutrophils. Immunology (1992) 0.77
Monoclonal antibody to the thrombin receptor stimulates DNA synthesis in combination with gamma-thrombin or phorbol myristate acetate. J Cell Biol (1987) 0.77
Inhibition of protein synthesis in frog (Xenopus laevis) egg extracts by an antibody against phosphatidylinositol 4,5-bisphosphate. Biochem J (1996) 0.76
Thrombin has a bimodal effect on glioma cell growth. Br J Cancer (1997) 0.75
Effect of thrombin on maturing human megakaryocytes. Am J Pathol (1993) 0.75
Charge Shielding of PIP2 by Cations Regulates Enzyme Activity of Phospholipase C. PLoS One (2015) 0.75
Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science (2001) 8.12
The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins. Nature (1995) 4.96
Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet (1987) 2.81
Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis (1984) 2.67
Sensorimotor changes and functional performance in patients with knee osteoarthritis. Ann Rheum Dis (1997) 2.39
The way forward for hydrotherapy. Br J Rheumatol (1993) 2.15
Cause of death in rheumatoid arthritis. Br J Rheumatol (1984) 2.12
The clinical features of chronic vitamin deficiency. A therapeutic trial in geriatric hospital patients. Gerontol Clin (Basel) (1968) 2.09
Can patients benefit from reading copies of their doctors' letters about them? Br Med J (Clin Res Ed) (1986) 2.04
The three-dimensional crystal structure of cholera toxin. J Mol Biol (1995) 2.03
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol (1998) 2.00
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis (1984) 1.86
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) (2005) 1.84
Lymphoedema of the limbs as an extra-articular feature of rheumatoid arthritis. Ann Rheum Dis (1990) 1.79
Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. Science (1990) 1.77
Heterogeneity among microtubules of the cytoplasmic microtubule complex detected by a monoclonal antibody to alpha tubulin. J Cell Biol (1984) 1.71
The long-term effects of treating rheumatoid arthritis. J R Coll Physicians Lond (1983) 1.70
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis (2007) 1.68
Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases. Ann Rheum Dis (1984) 1.66
Molecular characterization of a swelling-induced chloride conductance regulatory protein, pICln. Cell (1994) 1.66
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis (1992) 1.65
Frequency of occurrence, mode of development, and significance or rice bodies in rheumatoid joints. Ann Rheum Dis (1982) 1.62
Joint counts in routine practice. Rheumatology (Oxford) (2003) 1.62
Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) (2006) 1.58
What happens to patients with rheumatoid arthritis? The long-term outcome of treatment. Clin Rheumatol (1988) 1.58
Thrombin active site regions required for fibroblast receptor binding and initiation of cell division. J Biol Chem (1980) 1.56
The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol (2005) 1.51
Evidence that microtubule depolymerization early in the cell cycle is sufficient to initiate DNA synthesis. Cell (1981) 1.50
Quality of life, morbidity, and mortality after low trauma hip fracture in men. Ann Rheum Dis (2005) 1.48
Current concepts and new developments in the treatment of psoriatic arthritis. Rheumatology (Oxford) (2003) 1.47
Rest or exercise in inflammatory arthritis? Br J Hosp Med (1992) 1.47
Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis (2010) 1.45
Injections and physiotherapy for the painful stiff shoulder. Ann Rheum Dis (1989) 1.45
The distribution of fibronectin in the pannus in rheumatoid arthritis. Br J Exp Pathol (1981) 1.41
Septic arthritis complicating hip osteoarthritis. Ann Rheum Dis (1991) 1.40
Care giver perception of children's obesity-related health risk: a study of African American families. Obes Res (2000) 1.37
Improvements in quadriceps sensorimotor function and disability of patients with knee osteoarthritis following a clinically practicable exercise regime. Br J Rheumatol (1998) 1.35
Significance of fibronectin in rheumatoid arthritis and osteoarthrosis. Ann Rheum Dis (1981) 1.35
Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis. Ann Rheum Dis (1981) 1.31
Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol. Xenobiotica (1988) 1.30
Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology (2007) 1.28
Conditions which affect initiation of animal cell division by trypsin and thrombin. J Cell Physiol (1978) 1.26
The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoid. J Mol Biol (1995) 1.26
Cell surface action of thrombin is sufficient to initiate division of chick cells. Cell (1978) 1.25
Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis. Ann Rheum Dis (2007) 1.23
Instability of ventilatory control in patients with obstructive sleep apnea. Am J Respir Crit Care Med (1998) 1.23
Microtubule stabilization by taxol inhibits initiation of DNA synthesis by thrombin and by epidermal growth factor. Cell (1981) 1.20
Long term progression of joint damage in rheumatoid arthritis. Ann Rheum Dis (1986) 1.20
Initiation of check cell division by trypsin action at the cell surface. Nature (1977) 1.19
The management of knee pain in primary care: factors associated with consulting the GP and referrals to secondary care. Rheumatology (Oxford) (2006) 1.18
Organ-derived microvessel endothelial cells exhibit differential responsiveness to thrombin and other growth factors. Microvasc Res (1992) 1.18
Anti-rheumatic drugs and joint damage in rheumatoid arthritis. Q J Med (1985) 1.17
Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell culture. Proc Natl Acad Sci U S A (1978) 1.15
Clinical value of ELISA assays for IgM and IgG rheumatoid factors. J Clin Pathol (1987) 1.15
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis. Ann Rheum Dis (2007) 1.13
Studies on reticulin. I: Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulin. Br J Exp Pathol (1982) 1.13
Hand bone densitometry in rheumatoid arthritis, a five year longitudinal study: an outcome measure and a prognostic marker. Ann Rheum Dis (2003) 1.12
Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapy. Ann Rheum Dis (1986) 1.11
Cholesterol Stimulation of Penetration of Unilamellar Liposomes by Hydrophobic Compounds. J Membr Biol (1977) 1.11
A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology (Oxford) (2005) 1.10
Control of rheumatoid arthritis by oral tolerance. Arthritis Rheum (2001) 1.09
The K+ channel inward rectifier subunits form a channel similar to neuronal G protein-gated K+ channel. FEBS Lett (1996) 1.09
Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis. Rheumatology (Oxford) (2004) 1.09
WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.06
Bone mineral density, hip axis length and risk of hip fracture in men: results from the Cornwall Hip Fracture Study. Osteoporos Int (2000) 1.05
Thrombocytosis of active rheumatoid disease. Ann Rheum Dis (1983) 1.05
Fibronectin and immune complexes in rheumatic diseases. Ann Rheum Dis (1987) 1.03
Relationship of gold and penicillamine therapy to diffuse interstitial lung disease. Ann Rheum Dis (1981) 1.03
Cardiac pacemakers as an anaesthetic problem. Anaesthesia (1970) 1.03
Methods of X-ray assessment in rheumatoid arthritis: a re-evaluation. Br J Rheumatol (1985) 1.03
A survey of 216 elderly men and women in general practice. J R Coll Gen Pract (1971) 1.02
Role of specific cell surface receptors in thrombin-stimulated cell division. Cell (1978) 1.01
The preparation of plasma fibronectin antigen and antiserum. J Immunol Methods (1981) 1.01
Variations in responses to non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol (1982) 1.01
Patients' views on the quality of health care for rheumatoid arthritis. Rheumatology (Oxford) (2006) 1.01
The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Health Technol Assess (2005) 1.00
Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. Arthritis Rheum (1996) 1.00
2.0 A X-ray structure of the ternary complex of 7,8-dihydro-6-hydroxymethylpterinpyrophosphokinase from Escherichia coli with ATP and a substrate analogue. FEBS Lett (1999) 1.00
Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanisms. Ann Rheum Dis (1993) 1.00
Thrombin induces IL-6 production in fibroblasts and epithelial cells. Evidence for the involvement of the seven-transmembrane domain (STD) receptor for alpha-thrombin. J Immunol (1995) 0.99
Biosynthesis of acyl dihydroxyacetone phosphate in subcellular fractions of rat liver. J Biol Chem (1972) 0.99
Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1. Gen Pharmacol (2000) 0.99
The use of 'alternative treatments' by patients with rheumatoid arthritis. Rheumatol Int (1983) 0.98
Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis. Pept Res (1992) 0.98
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. J Rheumatol (2001) 0.98
Musculoskeletal disorders in patients with hyperlipidaemia. Ann Rheum Dis (1983) 0.98
Early referral and outcome in rheumatoid arthritis. Scand J Rheumatol (1998) 0.97
Joint space in radiologically normal knees. Br J Rheumatol (1991) 0.97
What proteins are present in polyethylene glycol precipitates from rheumatic sera? Ann Rheum Dis (1989) 0.97
Interventions for foot disease in rheumatoid arthritis: a systematic review. Arthritis Rheum (2005) 0.96
A pharmacist's audit of antirheumatic drugs. Rheumatol Rehabil (1982) 0.96
Septic arthritis and thigh abscess after dilatation and curettage. Clin Rheumatol (1984) 0.96
Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis: comparative effects of different antigens. Scand J Rheumatol (1998) 0.94
Sulphasalazine desensitisation in rheumatoid arthritis. Br Med J (Clin Res Ed) (1982) 0.94
Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis. J Rheumatol (1997) 0.94
Aphasia and hemiparesis following stellate ganglion block. Anesth Analg (1983) 0.93
The prevention and healing of acute non-steroidal anti-inflammatory drug-associated gastroduodenal mucosal damage by misoprostol. Br J Rheumatol (1993) 0.93
Enzymatic reduction of alkyl and acyl derivatives of dihydroxyacetone phosphate by reduced pyridine nucleotides. J Biol Chem (1972) 0.93